홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Triethylamine → 1-{1-[6-(4-Nitro-2,3-dihydroindole-1-carbonyl)-pyrimidin-4-yl]-piperidin-4-yl}-1,3-dihydroimidazo[4,5-b]pyridin-2-one

HRID 74529
인쇄

반응식

HRID 74529 반응식
CN(C(ON1N=NC2C=CC=CC1=2)=[N+](C)C)C.[B-](F)(F)(F)F.[O:23]=[C:24]1[NH:32][C:27]2=[N:28][CH:29]=[CH:30][CH:31]=[C:26]2[N:25]1[CH:33]1[CH2:38][CH2:37][N:36]([C:39]2[N:44]=[CH:43][N:42]=[C:41]([C:45](O)=[O:46])[CH:40]=2)[CH2:35][CH2:34]1.[N+:48]([C:51]1[CH:59]=[CH:58][CH:57]=[C:56]2[C:52]=1[CH2:53][CH2:54][NH:55]2)([O-:50])=[O:49].C(N(CC)CC)C>CN(C=O)C.O>[N+:48]([C:51]1[CH:59]=[CH:58][CH:57]=[C:56]2[C:52]=1[CH2:53][CH2:54][N:55]2[C:45]([C:41]1[N:42]=[CH:43][N:44]=[C:39]([N:36]2[CH2:37][CH2:38][CH:33]([N:25]3[C:26]4[C:27](=[N:28][CH:29]=[CH:30][CH:31]=4)[NH:32][C:24]3=[O:23])[CH2:34][CH2:35]2)[CH:40]=1)=[O:46])([O-:50])=[O:49]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

7

반응물 4

HCID 8471TriethylamineHCID 2733207O-(Benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborateHCID 132366324-Nitro-2,3-dihydro-1H-indoleHCID 583866966-[4-(2-Oxo-2,3-dihydroimidazo[4,5-b]pyridin-1-yl)-piperidin-1-yl]pyrimidine-4-carboxylic acid

생성물 1

HCID 583863791-{1-[6-(4-Nitro-2,3-dihydroindole-1-carbonyl)-pyrimidin-4-yl]-piperidin-4-yl}-1,3-dihydroimidazo[4,5-b]pyridin-2-one

시약·촉매·용매 2

HCID 962Water용매HCID 6228Dimethylformamide용매

실험 절차

150 mg (0.470 mmol) TBTU were added to 150 mg (0.44 mmol) 6-[4-(2-oxo-2,3-dihydro-imidazo[4,5-b]pyridin-1-yl)-piperidin-1-yl]-pyrimidine-4-carboxylic acid, 75 mg (0.46 mmol) 4-nitro-2,3-dihydro-1H-indole, 100 μL (0.712 mmol) triethylamine in 1.5 mL DMF and the mixture was stirred overnight at RT. The reaction mixture was poured onto 30 mL water. The aqueous phase was extracted with DCM (3×20 mL). The combined organic phases were dried on magnesium sulphate, filtered and evaporated down i. vac. The residue was dissolved in 3 mL DMF, filtered through a syringe filter and purified by preparative HPLC. The product fractions were combined and lyophilised.

후처리

  1. extractionThe aqueous phase was extracted with DCM (3×20 mL)
  2. customThe combined organic phases were dried on magnesium sulphate
  3. filtrationfiltered
  4. customevaporated down i
  5. dissolutionThe residue was dissolved in 3 mL DMF
  6. filtrationfiltered through a syringe
  7. filtrationfilter
  8. custompurified by preparative HPLC

출처 및 근거

ORD 기록
ord-cd8e6db8c4a94aeaa3ad584dd44fa0b7
출처 데이터셋
uspto-grants-2014_09
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08829006B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트